
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CORRECTION article
Front. Pharmacol. , 07 July 2023
Sec. Gastrointestinal and Hepatic Pharmacology
Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1231544
This article is a correction to:
Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules
A Corrigendum on
Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules
by Lv C, Li Y, Ou L, Zhou J, Peng F and Wu D (2023). Front. Pharmacol. 14:1122118. doi: 10.3389/fphar.2023.1122118
In the published article, there was an error in Figures 3, 6, 9 as published. The reason for this is a mistake was made in the order of BPC pictures of different tissue samples. The corrected Figures 3, 6 and 9 and their captions appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Ganlong capsule, hepatic fibrosis, CCl4, metabolomic analysis, LC-MS
Citation: Lv C, Li Y, Ou L, Zhou J, Peng F and Wu D (2023) Corrigendum: Metabonomic analysis of the anti-hepatic fibrosis effect of Ganlong capsules. Front. Pharmacol. 14:1231544. doi: 10.3389/fphar.2023.1231544
Received: 30 May 2023; Accepted: 04 July 2023;
Published: 07 July 2023.
Edited and reviewed by:
Shikai Yan, Shanghai Jiao Tong University, ChinaCopyright © 2023 Lv, Li, Ou, Zhou, Peng and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: DingYu Wu, ZmV0b2lvQHNpbmEuY29t
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.